Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC

Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC

Diffusion Pharmaceuticals Announces Strategic Review Process to Evaluate Value-Enhancing Alternatives including Opportunities to Better Leverage TSC 150 150 Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals Expands Clinical Trial Program of Tsc for the Treatment of COVID-19 Patients to Include the Romanian National Institute of Infectious Diseases
Back to top